Australian Story - Gunnings & Stehn, page-66

" Graham Kelly has overseen the design and implementation of thirty-three Phase I and II clinical trials, and a multinational Phase III trial in conjunction with the US FDA. "
------------------

Mr. Carmine's bio: "Bryce Carmine comes with 36 years of experience with one of the world's largest pharmaceutical companies, for much of that time at senior executive level, including being responsible for Eli Lilly's global late-stage drug development pipeline.
-----------------

Novogen just might be running in sync better then most think.

Glta!
Chris